Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer

NCT00971867 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Paclitaxel

Sponsor

Bristol-Myers Squibb